Company Filing History:
Years Active: 2006-2008
Title: David Mu - Innovator in Potassium Channel and Cancer Research
Introduction
David Mu is a notable inventor based in Jericho, NY (US). He has made significant contributions to the fields of molecular biology and cancer research. With a total of 2 patents, his work focuses on innovative methods for diagnosing and treating various medical conditions.
Latest Patents
One of David Mu's latest patents is titled "Nucleic acid encoding KCNB potassium channel." This invention provides nucleic acid and protein sequences for a novel potassium channel protein, KCNB. The disclosed sequences can be utilized for various purposes, including the specific detection of KCNB, identifying molecules that associate with or modulate KCNB activity, diagnosing conditions related to KCNB, and modulating KCNB molecules in mammals.
Another significant patent is "Diagnosis and treatment of cancer using mammalian pellino polypeptides and polynucleotides." This invention offers methods, reagents, and kits for diagnosing and treating cancer in mammals, particularly humans. It is based on the discovery that Pellino 1 or 2 is overexpressed and/or amplified in cancer. The methods include detecting cancer, monitoring treatment efficacy, and treating cancer by inhibiting Pellino 1 or 2 expression and activity in cancer cells.
Career Highlights
David Mu has worked with prominent companies in the biotechnology sector, including Amgen SF, LLC and Amgen Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in his field.
Collaborations
Throughout his career, David has collaborated with notable colleagues such as Scott Powers and Phil Xiang. These partnerships have further enhanced his research capabilities and innovation potential.
Conclusion
David Mu is a distinguished inventor whose work in potassium channel and cancer research has led to significant advancements in medical science. His patents reflect a commitment to improving diagnostic and treatment methods for critical health issues.